|
|
|
|
| LEADER |
01015caa a2200289 ir4500 |
| 001 |
NSK01000548819 |
| 003 |
HR-ZaNSK |
| 005 |
20070920083424.0 |
| 008 |
050131s2003 ci ||| ||eng |
| 015 |
|
|
|a HP03-7723
|2 HR
|
| 035 |
|
|
|9 (HR-ZaNSK)549754
|
| 035 |
|
|
|9 (HR-ZaNSK)450131157
|
| 035 |
|
|
|a (HR-ZaNSK)000548819
|
| 040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
| 041 |
0 |
|
|a eng
|
| 080 |
|
|
|a 616-006.44
|
| 100 |
1 |
|
|a Child, J. Anthony
|
| 245 |
1 |
4 |
|a The MRC myeloma trials :
|b what we have learned and future strategies /
|c J. Anthony Child.
|
| 246 |
1 |
3 |
|a The Medical research council
|
| 300 |
|
|
|b Ilustr.
|
| 500 |
|
|
|a 3. hrvatski kongres hematologa i transfuziologa s međunarodnim sudjelovanjem, Opatija, 23-26.10.2003
|
| 504 |
|
|
|a Bibliografija: 12 jed.
|
| 650 |
|
7 |
|a Plazmocitom
|2 nskps
|
| 773 |
0 |
|
|t Liječnički vjesnik. Suplement
|x 1330-4917
|g 125 (2003), 3 ; str. 34-36
|w nsk.(HR-ZaNSK)000053054
|
| 981 |
|
|
|z B11/03
|
| 998 |
|
|
|a LUKo0501
|a bokp0502
|c vebo050604
|
| 886 |
0 |
|
|2 unimarc
|b 00813iaa2 2200229 450
|